NEW YORK (TheStreet) -- Facebook (FB) - Get Meta Platforms Inc. Class A Report was jumping 3.7% to $57.13 after estimates and price target were raised by Cantor Fitzgerald. Shares are expected to reach $65 within 12 months, Cantor said. the shares are rated a buy.
Blackberryundefined was falling 0.7% to $7.17 as the shares were downgraded at Hudson Square to sell from hold. $5 price target. Service revenue is falling and the company continues to burn cash, Hudson Square said.
Salesforce.com (CRM) - Get salesforce.com, inc. Report was rising 1% to $54.24 as coverage of the stock was initiated with an outperform rating at BMO Capital. $62 price target. Company is positioned well for long-term growth, BMO Capital said.
Darling (DAR) - Get Darling Ingredients Inc. Report was adding 1% to $20.75 as the shares were upgraded at BMO Capital to outperform. New analyst has a $25 price target. Acquisitions and JV should drive earnings growth, BMO Capital said.
Five Below (FIVE) - Get Five Below, Inc. Report was jumping 3.7% to $44.30 as the shares were upgraded at Credit Suisse to outperform from neutral. $52 price target. Increasingly compelled by the combination of dollar store attributes and specialty retailer disciplines.
Fortinet (FTNT) - Get Fortinet, Inc. Report was advancing 2.7% to $18.92 after being upgraded at Robert Baird to outperform from neutral. $25 price target. New CFO is a positive catalyst and the company should benefit from better security spending, Robert Baird said.
Micron (MU) - Get Micron Technology, Inc. Report was falling 3.7% to $21.35 after shares were downgraded at Bank of America/Merrill Lynch to underperform. $19.50 price target. Consensus earnings expectations appear too high, BofA/Merrill said.
United Therapeutics (UTHR) - Get United Therapeutics Corporation Report was surging 24% to $108.48 on an upgraded by J.P. Morgan to neutral. $90 price target. FDA approval for Orenitram was a surprise, J.P. Morgan said.
Xilinx (XLNX) - Get Xilinx, Inc. Report added 0.4% to $44.89 after shares were upgraded at Drexel Hamilton to buy from hold. $50 price target. China 4G buildout gaining momentum, Drexel Hamilton said.
[Read:Alaska Air Gets Quarterback, Ratings Upgrade]
Stock Comments / EPS Changes
Cintas (CTAS) - Get Cintas Corporation Report estimates, price target were increased at Credit Suisse. Shares were little changed at $59.23 Estimates were raised through 2015. Company is seeing organic growth and higher margins in all business lines, Credit Suisse said. Neutral rating and new $60 price target.
[Read:Top 10 Financial Heroes of 2013]
Finish Line (FINL) was adding 1% to $28.04 as earnings were boosted at Canaccord Genuity. Shares are now seen reaching $32. Estimates were also increased, as management has the company back on the right track, Canaccord said. Buy rating.
This article was written by a staff member of TheStreet.